Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Shortly Propose Policy for Health Insurance Reform: Senior Official
September 30, 2002
- b-blockers Not Always More Effective than Ca Antagonists
September 30, 2002
- BUSINESS NEWS IN BRIEF
September 30, 2002
- COLIN Medical Instruments Receives FDA Approval for Prodigy
September 30, 2002
- NEW PRODUCTS
September 30, 2002
- Terumo Prepares CD-ROM on Proper Use of Drip Infusion Pumps
September 30, 2002
- Kyorin Revises Business Forecasts Downward
September 30, 2002
- GEYMS: New Multislice CT, LightSpeed Ultra16
September 30, 2002
- Medical Vita Japan Recruits Trial Subjects for Medical Institutions
September 30, 2002
- New Nursing Care Fees to Be Set in January
September 30, 2002
- MRs Banned to Serve as Carriers of Medical Bills: Maker FTC
September 30, 2002
- Safety Items to Be Included in Exam for Medical Professionals
September 30, 2002
- Mr Matsutani Committed to Success of IFPW Meeting in 2004 in Asia
September 30, 2002
- Pharmaceutical Education GL Presented
September 30, 2002
- Meiji Seika Expands MR Support System for Immediate PMS for Sword
September 30, 2002
- REGULATORY NEWS IN BRIEF
September 30, 2002
- Pharma Delegates Provides Opportunity to Open Communication: Chairman Brrunger
September 30, 2002
- eCTD Reaches Final ICH Step 4 at Washington Meeting
September 30, 2002
- Banyu to Boost Its Sales to \300 Bil. by FY2007: Mr Nagasaka
September 23, 2002
- Cancer Risk Increases with Level of Alcohol Consumption: Korosho Report
September 23, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…